Alzheimer's Drug Discovery Foundation
@TheADDF
Followers
19K
Following
3K
Media
2K
Statuses
6K
The Alzheimer's Drug Discovery Foundation's mission is to rapidly accelerate the discovery and development of drugs to prevent, treat, and cure #Alzheimers.
New York, NY
Joined February 2009
@EsteeLauder Our dynamic symposium, moderated by @TheADDFCEO with @a_hfillit, Sarah Foster, @EisaiUS, Sarah Kleinpeter, @Biogen & Laura Steele, @EliLilly explored the next era of precision medicine in Alzheimer’s research, driving progress toward prevention, treatment & cure.
0
1
2
The Annual Fall Symposium & Luncheon celebrated 27 years of vision from Leonard & Ronald Lauder, inspiring science & honorees! Phebe Farrow Port, @EsteeLauder received the Charles Evans Award and Martha & Peter Webster received the Visionary Partner Award. https://t.co/ccvt1sH0Nn
1
0
0
AI Infrastructure is exploding, where does “the network” stand? @Cisco President & CPO Jeetu Patel (@jpatel41) joins @DanielNewmanUV at Cisco’s Partner Summit to discuss the boom in AI infrastructure, emphasizing the pivotal role of the network in delivering secure, low-latency
0
1
6
Thank you New York! It was an epic day for my 11th @NYCMarathon to support @TheADDF and its vital Alzheimer’s research. Grateful to everyone who supported. Onward! 🏃🏽
0
2
8
Gearing up for Sunday’s @NYCMarathon! I’m running it for the 11th time to support @TheADDF and its vital Alzheimer’s research: https://t.co/NLqkqMcYz0 Go team!
1
1
7
We’re pleased to be joined by Dr Laura Nisenbaum from @TheADDF as our co-chair. Providing a warm welcome, she’s sharing insights on the research pipeline and investment into biomarker discovery.
0
1
2
PLEA FOR GOSU — 8-YEAR-OLD SHEPHERD, LOST HIS HUMAN, ABOUT TO LOSE HIS LIFE! Gosu shouldn’t be fighting for his life right now! Fourteen days ago, this sweet loyal older guy was brought to ACC along with his 5 year old Shepherd brother. Gosu's owner passed away. He lost his
1
10
31
The ADDF celebrates the opening of the Center for Aging Well at @YaleNursing, led by Dr. @MiiaKivipelto. Her pioneering work in brain health and aging continues to shape the future of precision prevention and Alzheimer’s care. https://t.co/dNDVkdijo8
0
0
1
🧠 World Dementia Council reminder: Our next virtual event “Lessons from innovators: biomarkers“ is tomorrow! We'll be discussing vital, collaborative work that is shaping the future of dementia research and care worldwide. Learn more: https://t.co/nXPdBq1keC
0
3
12
In a special Power of Ideas series, @a_hfillit highlighted the pivotal inflection point Alzheimer’s science has reached in recent years. The ADDF is driving breakthroughs through bold partnerships and cross-sector collaboration. @MilkenInstitute
https://t.co/oj97fhHEnC
0
0
2
Innovation is transforming #Alzheimer’s care. @a_hfillit joins Dr. Jeffrey Borenstein to discuss new diagnostic tools that bring us closer to earlier and more accurate detection, highlighting how these advances speak to the mission of the DxA. https://t.co/uFCdvngrgc
thirteen.org
New advances in blood tests for biomarkers mean earlier diagnosis and defined categories of Alzheimer’s disease enabling doctors to delay onset of symptoms, with lower costs to patients and higher...
0
1
2
Join us for our upcoming virtual event, “Lessons from innovators: biomarkers,” exploring recent advances & future opportunities in biomarker development. Chaired by @a_hfillit & Dr Stacie Weninger. Find out more: https://t.co/nXPdBq0Mp4
0
1
7
Daniel Skovronsky, @EliLillyandCo, Chief Scientific Officer and ADDF Goodes Prize Winner, sat down with @statnews to discuss early-stage ideas that could drive the next generation of medical breakthroughs and the future of #Alzheimer’s treatment. https://t.co/3X3lQCSwH0
statnews.com
In San Diego for the opening of Lilly's latest Gateway Labs biotech incubator, CSO Daniel Skovronsky spoke broadly about the company’s R&D plans
0
0
4
This is really, really fascinating (and promising):
Can GLP-1s also combat Alzheimer’s? @novonordisk's EVOKE trial results will be presented at @CTADconference, building on ADDF-funded research by Dr. Paul Edison on liraglutide. Repurposed drugs & precision medicine could redefine how we treat #Alzheimer’s.
0
3
4
Can GLP-1s also combat Alzheimer’s? @novonordisk's EVOKE trial results will be presented at @CTADconference, building on ADDF-funded research by Dr. Paul Edison on liraglutide. Repurposed drugs & precision medicine could redefine how we treat #Alzheimer’s.
ft.com
Results are due soon from two studies using semaglutide to treat thousands of people with the disease
1
2
5
Alzheimer’s care is evolving. The FDA clearance of @Roche and @EliLillyandCo’s Elecsys pTau181 blood test marks a major step toward accessible, scalable diagnostics that bring detection into everyday clinical care. @CNN
https://t.co/BJJplUuKcH
cnn.com
The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the...
0
0
5
Our next virtual event: “Lessons from innovators: biomarkers” is coming up on 31 October. Supported by @theaddf, this dialogue will explore the rapid advances and key challenges in developing new dementia diagnostics. Find out more: https://t.co/nXPdBq0Mp4
0
2
4
Exciting news from our funded investigator, @CoyaTx! Dr. Shimon Sakaguchi, a Scientific Advisor for the organization, is one of three scientists to receive this year’s Nobel Prize in Physiology or Medicine. Congratulations on this incredible achievement!
We’re proud to congratulate our Scientific Advisor, Dr. Shimon Sakaguchi, on being one of three scientists to receive this year’s Nobel Prize in Physiology or Medicine. His discovery of regulatory T cells (#Tregs) transformed our understanding of immune tolerance and
0
0
2
We’re proud to celebrate @EisaiUS and @biogen for Leqembi Iqlik being named one of @TIME's Best Inventions of 2025. This marks incredible innovation in Alzheimer’s care, paving the way for faster delivery that can be self-administered at home like GLP-1s.
time.com
Find out why Eisai and Biogen Leqembi Iqlik is on TIME's list of 2025's best inventions.
0
1
2
Dr. Brinton was honored as Inventor of the Year at last night's I-squared Expo and Awards, presented by the University of Arizona's Tech Launch Arizona (TLA). TLA is the guiding force in moving inventions stemming from university research to the marketplace. @UAZTechLaunch
0
1
4
Congratulations to our friend and partner Anne White, who has been named one of @endpointsnews’ Women in Biopharma 2025. Anne’s impact and leadership at @EliLillyandCo from advancing oncology to Alzheimer’s breakthroughs continues to transform the field. https://t.co/9R5PZVKJJw
endpoints.news
A project highlighting women in biopharma has grown since 2019, now honoring over 140 women who've shaped the industry through work on rare diseases, IPOs, AI drug discovery and patient advocacy....
0
0
2
"The dementia field is at a turning point," says WDC Executive Director @lennyshallcross, opening our session "Advancing Advocacy: From Discovery to Delivery in Prevention and Treatment." This discussion will explore how advocacy must evolve as science advances. #35AEC
0
3
14
What do people really think of recycled rubber and artificial turf? According to BPI’s recent survey, a strong majority of Americans see these surfaces as safe. In fact, when given a choice, 72% would choose artificial turf over grass when upgrading local fields. Confidence
2
5
7